Highly multiplexed imaging by Cyclic Immunofluorescence (CycIF) of protein levels and protein phosphorylation states in the COLO 858 melanoma cell line - Dataset (ID:20236)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit Timepoint Timepoint Unit Raw Image Registered Image CycIF Round Primary Antibody Secondary Antibody Cytell filter Protein Detected Other Reagent Detected Measured Fluorescence Intensity (a.u.) Field Cell ID Number X-coordinate Y-coordinate Cell Area (um^2) Cell Perimeter (um) Cell Circularity
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 354.3 4
0019-0086
80.39 85.76 433 82.08 0.808
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 3254.3 4
0020-0090
179.51 90.53 727 103.64 0.851
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 257.8 4
0021-0096
849.52 96.88 428 81.15 0.817
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 3512.9 4
0022-0097
118.83 97.58 763 103.40 0.897
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 358.3 4
0023-0100
519.10 99.71 481 85.74 0.822
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 457.0 4
0024-0100
348.91 100.90 383 75.50 0.844
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 284.1 4
0025-0102
889.05 102.48 431 77.26 0.907
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 549.9 4
0026-0105
706.22 105.50 424 76.67 0.906
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 389.1 4
0027-0114
78.30 115.10 429 85.26 0.742
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 341.0 4
0028-0113
624.49 113.53 484 84.33 0.855
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 598.3 4
0029-0115
801.67 114.62 416 77.50 0.870
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 2226.9 4
0030-0116
387.80 116.12 561 90.08 0.869
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 299.3 4
0031-0123
266.03 123.08 434 78.43 0.887
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 415.0 4
0032-0124
770.35 123.97 438 80.91 0.841
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 484.6 4
0033-0124
676.92 124.50 422 76.67 0.902
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 314.3 4
0034-0142
319.72 142.15 433 79.74 0.856
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 367.7 4
0035-0148
217.28 148.11 423 76.43 0.910
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 322.2 4
0036-0153
718.54 153.51 431 82.77 0.791
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 553.4 4
0037-0159
843.33 158.44 853 112.71 0.844
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 788.1 4
0038-0158
145.77 159.32 864 116.23 0.804
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 389.2 4
0039-0168
270.56 168.62 924 119.88 0.808
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 790.8 4
0040-0168
358.99 168.27 488 84.33 0.862
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 295.4 4
0041-0166
664.94 166.66 434 79.50 0.863
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 293.9 4
0042-0172
406.55 172.28 479 82.67 0.881
COLO 858 Vemurafenib
0.1
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 391.5 4
0043-0173
716.05 172.21 435 79.11 0.873